Ten years after the discovery of human es cells, scientists are still working on standardizing procedures for coaxing pluripotent cells to become mature tissue.
在发现人类胚胎干细胞的十年之后,科学家们仍致力于研究将多能细胞“哄骗”成为成熟组织细胞的标准过程。
Objective: to understand the changes in hematopoietic growth factor receptors during erythroid differentiation of pluripotent cells.
目的:了解多潜能造血祖细胞向红系分化过程中造血因子受体的改变。
This paper reviewed the progress of new drug research of the directed differentiation of embryonic stem cells, bone marrow mesenchymal stem cells and induced pluripotent cells.
本文主要综述胚胎干细胞、骨髓间充质干细胞、多能性诱导干细胞的定向分化在新药研发中的作用及研究进展。
Professor Schneider continued: "Using heart-derived stem cells to treat heart attack and cardiomyopathy has some advantages over embryonic and induced pluripotent cells as they are potentially safer."
Schneider教授继续说:“利用心脏衍生干细胞来治疗心脏病发作和心肌病比胚胎干细胞(包括多潜能细胞)具有一些优势,而且他们可能更安全。”
Professor Schneider continued: "Using heart-derived stem cells to treat heart attack and cardiomyopathy has some advantages over embryonic and induced pluripotent cells as they are potentially safer."
Schneider教授继续说:“利用心脏衍生干细胞来治疗心脏病发作和心肌病比胚胎干细胞(包括多潜能细胞)具有一些优势,而且他们可能更安全。”
应用推荐